Inhibrx Biosciences Inc (INBX)
Cash & Equivalents
$133.34M
Quarterly · Period ending: · USD
INBX Cash & Equivalents
Latest reported$133.34Mperiod ending
Latest reported$133.34Mperiod ending
INBX Quarterly Cash & Equivalents ($13.47M → $133.34M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
INBX cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 133,344,000 | |
| 161,657,000 | |
| 124,220,000 | |
| 153,088,000 | |
| 186,567,000 | |
| 216,520,000 | |
| 152,596,000 | |
| 196,332,000 | |
| 226,860,000 | |
| 252,483,000 | |
| 277,924,000 | |
| 337,327,000 | |
| 192,492,000 | |
| 234,254,000 | |
| 273,865,000 | |
| 146,073,000 | |
| 176,385,000 | |
| 143,467,000 | |
| 131,301,000 | |
| 112,704,000 | |
| 125,728,000 | |
| 107,990,000 | |
| 128,664,000 | |
| 127,669,000 | |
| 5,632,000 | |
| 428,000 | |
| 11,540,000 | |
| 27,625,000 | |
| 6,244,000 | |
| 2,103,000 | |
| -13,470,000 | |
| 13,470,000 |